Quintiles: Strategic ally for the healthcare industry offers solutions
Mannheim, 5. October 2010 – The healthcare market is experiencing significant changes: new legislation, already having been implemented or planned to go in early 2011, will bring drastic changes to the entire German healthcare system. The development of highly specialized drugs and therapies is getting more expensive, while at the same time companies are facing difficulties in getting appropriate financial support for these projects. Against this background, the government is asking for affordable drugs, physicians and regulatory bodies want see the added value for high-priced products, and also payers as well as patients are playing a more important role in the decision process.